Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Toceranib (PHA 291639E) phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,000 | |||
25 mg | 在庫あり | ¥ 13,500 | |||
50 mg | 在庫あり | ¥ 18,500 | |||
100 mg | 在庫あり | ¥ 27,000 |
ターゲット&IC50 | PDGFRβ:5 nM (ki), FLK1:6 nM (ki) |
別名 | PHA 291639E, SU11654 |
分子量 | 396.46 |
分子式 | C22H25FN4O2 |
CAS No. | 356068-94-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.4 mg/mL (6.05 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Toceranib 356068-94-5 Angiogenesis Tyrosine Kinase/Adaptors VEGFR PDGFR c-Kit SCFR CD117 SU-11654 Vascular endothelial growth factor receptor inhibit Platelet-derived growth factor receptor Inhibitor PHA 291639E SU 11654 SU11654 inhibitor